| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |